List of Contributors |
|
xv | |
Preface |
|
xvii | |
Acknowledgements to Contributors of the First Edition |
|
xix | |
|
|
|
|
2 Introduction to First Edition |
|
|
|
|
|
|
|
|
4 | (3) |
|
|
|
|
|
|
7 | (1) |
|
|
7 | (2) |
|
|
8 | (1) |
|
|
9 | (1) |
|
2.3 Sprague-Dawley Strain |
|
|
9 | (1) |
|
3 Use of the Rat Strains in Chronic Carcinogenicity Studies |
|
|
9 | (2) |
|
|
9 | (1) |
|
|
10 | (1) |
|
3.3 Sprague-Dawley Strain |
|
|
11 | (1) |
|
4 Comparison of the Rat Strains for Early Onset of Neoplasms |
|
|
11 | (1) |
|
|
12 | (1) |
|
|
12 | (3) |
Section I Digestive System |
|
|
4 Oral Cavity, Teeth and Gingiva |
|
|
|
|
|
|
15 | (1) |
|
|
15 | (1) |
|
|
15 | (1) |
|
|
16 | (1) |
|
|
16 | (1) |
|
|
17 | (1) |
|
|
17 | (1) |
|
4 Inflammatory and Vascular Lesions |
|
|
17 | (1) |
|
|
17 | (1) |
|
5 Hyperplastic and Neoplastic Lesions |
|
|
17 | (1) |
|
|
17 | (1) |
|
|
18 | (2) |
|
|
18 | (2) |
|
|
20 | (3) |
|
|
|
|
|
|
23 | (1) |
|
|
23 | (3) |
|
2.1 Embryology and Perinatal Development |
|
|
23 | (1) |
|
2.2 Anatomy and Histology |
|
|
23 | (3) |
|
|
26 | (1) |
|
|
26 | (1) |
|
|
26 | (2) |
|
5 Inflammatory and Vascular Lesions |
|
|
28 | (1) |
|
6 Hyperplastic and Neoplastic Lesions |
|
|
28 | (4) |
|
6.1 Basophilic Hypertrophic Foci |
|
|
28 | (1) |
|
|
29 | (1) |
|
|
29 | (1) |
|
6.4 Squamous Cell Carcinoma |
|
|
30 | (1) |
|
6.5 Mesenchymal Neoplasms |
|
|
31 | (1) |
|
|
32 | (1) |
|
|
33 | (2) |
|
|
|
|
|
|
|
35 | (1) |
|
2 Normal Upper Digestive Tract |
|
|
35 | (3) |
|
|
35 | (1) |
|
|
36 | (1) |
|
|
36 | (2) |
|
|
38 | (1) |
|
|
38 | (1) |
|
|
39 | (1) |
|
|
39 | (1) |
|
|
39 | (1) |
|
5 Inflammatory and Vascular Lesions |
|
|
40 | (1) |
|
|
40 | (1) |
|
|
40 | (1) |
|
6 Hyperplastic and Neoplastic Lesions |
|
|
41 | (5) |
|
|
41 | (1) |
|
|
41 | (5) |
|
|
46 | (1) |
|
|
46 | (2) |
|
|
46 | (1) |
|
|
46 | (2) |
|
|
48 | (3) |
|
7 Small and Large Intestine |
|
|
|
|
|
|
|
51 | (1) |
|
|
51 | (4) |
|
|
51 | (1) |
|
2.2 Anatomy and Histology |
|
|
52 | (2) |
|
|
54 | (1) |
|
|
55 | (1) |
|
|
55 | (1) |
|
5 Inflammatory and Vascular Lesions |
|
|
56 | (1) |
|
6 Hyperplastic and Neoplastic Lesions |
|
|
57 | (6) |
|
|
57 | (1) |
|
|
58 | (5) |
|
|
63 | (1) |
|
|
64 | (4) |
|
|
68 | (3) |
|
8 Peritoneum, Retroperitoneum, Mesentery, and Abdominal Cavity |
|
|
|
|
|
71 | (1) |
|
|
71 | (1) |
|
|
71 | (1) |
|
2.2 Anatomy and Histology |
|
|
71 | (1) |
|
|
72 | (1) |
|
|
72 | (1) |
|
5 Inflammatory and Vascular Lesions |
|
|
73 | (1) |
|
6 Hyperplastic and Neoplastic Lesions |
|
|
73 | (3) |
|
|
76 | (1) |
|
|
76 | (1) |
|
|
76 | (5) |
Section II Liver and Exocrine Pancreas |
|
|
|
|
|
|
81 | (1) |
|
|
81 | (4) |
|
|
81 | (1) |
|
|
82 | (2) |
|
|
84 | (1) |
|
|
85 | (1) |
|
|
85 | (1) |
|
|
86 | (3) |
|
4.1 Lipidosis/Steatosis/Fatty Accumulation |
|
|
86 | (1) |
|
4.2 Necrosis and Apoptosis |
|
|
87 | (2) |
|
4.3 Cystic Degeneration/Spongiosis Hepatis |
|
|
89 | (1) |
|
|
89 | (1) |
|
4.5 Hepatic Cysts (Biliary) |
|
|
89 | (1) |
|
5 Inflammatory and Vascular Lesions |
|
|
89 | (2) |
|
|
89 | (1) |
|
5.2 Angiectasis (Telangiectasis, Peliosis Hepatis) |
|
|
90 | (1) |
|
6 Hyperplastic and Neoplastic Lesions |
|
|
91 | (10) |
|
6.1 Hepatocellular Lesions |
|
|
91 | (4) |
|
|
95 | (2) |
|
6.3 Miscellaneous Lesions |
|
|
97 | (4) |
|
|
101 | (4) |
|
|
101 | (1) |
|
|
102 | (2) |
|
7.3 Extramedullary Hematopoiesis |
|
|
104 | (1) |
|
|
105 | (1) |
|
|
105 | (2) |
|
|
|
|
|
|
|
107 | (1) |
|
10.2 Normal Exocrine Pancreas |
|
|
107 | (3) |
|
|
107 | (1) |
|
|
108 | (1) |
|
|
108 | (1) |
|
|
109 | (1) |
|
|
110 | (1) |
|
10.4 Degenerative Lesions |
|
|
110 | (3) |
|
10.4.1 Hydropic Degeneration, Fatty Degeneration, and Autophagocytosis (Apoptosis) |
|
|
110 | (1) |
|
|
111 | (1) |
|
|
111 | (1) |
|
|
112 | (1) |
|
10.4.5 Peri-Islet Fibrosis and Hemosiderosis |
|
|
112 | (1) |
|
10.5 Inflammatory and Vascular Lesions |
|
|
113 | (1) |
|
10.6 Hyperplastic and Neoplastic Lesions |
|
|
113 | (4) |
|
10.6.1 Acinar Cell Hyperplasia |
|
|
114 | (1) |
|
10.6.2 Acinar Cell Adenoma |
|
|
115 | (1) |
|
10.6.3 Acinar Cell Carcinoma |
|
|
115 | (1) |
|
10.6.4 Mixed Acinar-Islet Cell Adenoma |
|
|
116 | (1) |
|
10.7 Miscellaneous Lesions |
|
|
117 | (1) |
|
10.7.1 Basophilic Cytoplasmic Change |
|
|
117 | (1) |
|
10.7.2 Hepatocyte Metaplasia |
|
|
117 | (1) |
|
|
118 | (2) |
|
|
120 | (5) |
Section III Urinary Tract |
|
|
|
|
|
|
|
|
125 | (1) |
|
|
126 | (8) |
|
|
126 | (1) |
|
|
127 | (1) |
|
|
127 | (6) |
|
|
133 | (1) |
|
|
134 | (1) |
|
|
135 | (6) |
|
4.1 Chronic Progressive Nephropathy |
|
|
135 | (2) |
|
4.2 Acute Tubule Necrosis |
|
|
137 | (1) |
|
|
138 | (3) |
|
5 Inflammatory and Vascular Lesions |
|
|
141 | (3) |
|
6 Hyperplastic and Neoplastic Lesions |
|
|
144 | (11) |
|
6.1 Renal Tubule Epithelium |
|
|
144 | (5) |
|
|
149 | (4) |
|
6.3 Renal Pelvic Urothelium |
|
|
153 | (2) |
|
|
155 | (1) |
|
|
155 | (1) |
|
|
156 | (6) |
|
9.1 General Considerations |
|
|
156 | (1) |
|
|
157 | (1) |
|
|
157 | (2) |
|
|
159 | (1) |
|
|
160 | (1) |
|
9.6 Specific Forms of Nephrotoxicity |
|
|
160 | (2) |
|
9.7 Experimentally Induced Renal Carcinogenesis |
|
|
162 | (1) |
|
|
162 | (5) |
|
12 Urinary Bladder, Ureter, and Urethra |
|
|
|
|
|
|
167 | (1) |
|
|
167 | (5) |
|
|
167 | (1) |
|
2.2 Anatomy and Histology |
|
|
168 | (3) |
|
|
171 | (1) |
|
|
172 | (1) |
|
|
172 | (1) |
|
5 Hyperplastic and Neoplastic Lesions |
|
|
173 | (9) |
|
5.1 Urothelial Hyperplasia and Metaplasia |
|
|
173 | (3) |
|
|
176 | (6) |
|
|
182 | (3) |
|
|
182 | (1) |
|
6.2 Trichosomoides crassicauda (Bladder Threadworm) |
|
|
183 | (1) |
|
|
184 | (1) |
|
|
184 | (1) |
|
|
185 | (1) |
|
|
185 | (1) |
|
8 Experimentally Induced Urinary Bladder Carcinogenesis |
|
|
185 | (1) |
|
|
186 | (5) |
Section IV Nervous System and Special Sense Organs |
|
|
|
|
|
|
|
|
|
|
191 | (7) |
|
|
194 | (2) |
|
|
196 | (2) |
|
|
198 | (1) |
|
|
198 | (5) |
|
|
198 | (1) |
|
3.2 Basophilic Bodies/Mineralization |
|
|
199 | (1) |
|
|
199 | (1) |
|
|
199 | (1) |
|
3.5 Neuronal Degeneration and Necrosis |
|
|
200 | (1) |
|
3.6 Neuronal Pigmentation |
|
|
200 | (1) |
|
|
201 | (1) |
|
3.8 Degenerative Changes Affecting Axons and Myelin Within the CNS |
|
|
201 | (1) |
|
3.9 Neuronal Chromatolysis |
|
|
202 | (1) |
|
|
202 | (1) |
|
3.11 Inflammatory and Vascular Lesions |
|
|
202 | (1) |
|
|
203 | (1) |
|
4.1 Granular Cell Hyperplasia |
|
|
203 | (1) |
|
|
204 | (7) |
|
|
205 | (1) |
|
|
205 | (3) |
|
|
208 | (3) |
|
|
211 | (2) |
|
6.1 Primary Toxic Damage to Neurons (Toxic Neuronopathies) |
|
|
212 | (1) |
|
6.2 Primary Damage to Axons (Toxic Axonopathies) |
|
|
212 | (1) |
|
6.3 Primary Damage to Myelin (Toxic Myelinopathies) |
|
|
212 | (1) |
|
6.4 Toxic Damage to Astrocytes |
|
|
213 | (1) |
|
6.5 Toxic Damage to Microglia |
|
|
213 | (1) |
|
6.6 Miscellaneous Toxic Lesions |
|
|
213 | (1) |
|
|
213 | (4) |
|
14 The Spinal Cord and Peripheral Nervous System |
|
|
|
|
|
|
|
|
1 Spinal Cord and Peripheral Nerves |
|
|
217 | (12) |
|
|
217 | (1) |
|
1.2 Embryology and Anatomy |
|
|
218 | (2) |
|
1.3 Sampling and Histology |
|
|
220 | (2) |
|
|
222 | (1) |
|
|
223 | (1) |
|
1.6 Inflammatory and Vascular Lesions |
|
|
224 | (1) |
|
1.7 Hyperplastic and Neoplastic Lesions |
|
|
225 | (4) |
|
|
229 | (2) |
|
|
231 | (4) |
|
3.1 Primary Damage to Perikarya of Peripheral Neurons |
|
|
231 | (2) |
|
3.2 Primary Damage to Axons of Peripheral Neurons |
|
|
233 | (1) |
|
3.3 Primary Damage to Myelin Sheaths or Schwann Cells |
|
|
234 | (1) |
|
3.4 Induced Neoplastic Lesions |
|
|
235 | (1) |
|
4 Animal Models of Peripheral Neuropathies |
|
|
235 | (1) |
|
|
236 | (5) |
|
|
241 | (11) |
|
|
|
|
241 | (1) |
|
|
241 | (3) |
|
|
241 | (1) |
|
2.2 Anatomy and Histology |
|
|
241 | (3) |
|
|
244 | (1) |
|
|
244 | (1) |
|
|
244 | (1) |
|
5 Inflammatory and Vascular Lesions |
|
|
244 | (2) |
|
|
244 | (1) |
|
|
245 | (1) |
|
|
246 | (1) |
|
|
246 | (1) |
|
6 Hyperplastic and Neoplastic Lesions |
|
|
246 | (1) |
|
|
246 | (1) |
|
|
246 | (1) |
|
7 Neural Crest Neoplasm of the Pinna |
|
|
247 | (1) |
|
|
248 | (1) |
|
|
248 | (1) |
|
|
248 | (1) |
|
|
249 | (3) |
|
16 Eye and Associated Glands |
|
|
|
|
|
|
|
252 | (1) |
|
2 Normal Eye and Associated Glands |
|
|
252 | (8) |
|
|
252 | (1) |
|
2.2 Anatomy and Histology |
|
|
253 | (4) |
|
|
257 | (3) |
|
|
260 | (1) |
|
|
261 | (5) |
|
|
261 | (4) |
|
|
265 | (1) |
|
5 Inflammatory and Vascular Lesions |
|
|
266 | (1) |
|
|
266 | (1) |
|
|
267 | (1) |
|
6 Hyperplastic and Neoplastic Lesions |
|
|
267 | (4) |
|
|
268 | (1) |
|
|
269 | (1) |
|
|
270 | (1) |
|
|
270 | (1) |
|
|
271 | (1) |
|
|
271 | (1) |
|
|
271 | (1) |
|
|
272 | (2) |
|
|
272 | (2) |
|
|
274 | (1) |
|
|
274 | (7) |
Section V Musculoskeletal System |
|
|
|
|
|
|
|
|
281 | (1) |
|
|
281 | (4) |
|
|
281 | (1) |
|
|
282 | (1) |
|
2.3 Histologic and Ultrastructural Features |
|
|
282 | (3) |
|
|
285 | (1) |
|
|
285 | (1) |
|
|
285 | (3) |
|
|
285 | (1) |
|
|
285 | (1) |
|
4.3 Degeneration and Necrosis |
|
|
286 | (1) |
|
|
286 | (1) |
|
|
287 | (1) |
|
4.6 Nutritional Disorders |
|
|
288 | (1) |
|
5 Parasitic, Inflammatory, and Vascular Lesions |
|
|
288 | (1) |
|
6 Hyperplastic and Neoplastic Lesions |
|
|
288 | (1) |
|
|
289 | (1) |
|
7.1 Hind Leg Myopathy of Aging Rats |
|
|
289 | (1) |
|
|
289 | (1) |
|
|
290 | (2) |
|
|
292 | (1) |
|
|
292 | (7) |
|
18 Bones, Joints, and Synovia |
|
|
|
|
|
|
|
299 | (1) |
|
2 Normal Bones, Joints, and Synovia |
|
|
299 | (5) |
|
|
299 | (1) |
|
|
300 | (1) |
|
|
300 | (3) |
|
|
303 | (1) |
|
|
304 | (1) |
|
3 Non-proliferative Lesions |
|
|
304 | (7) |
|
|
304 | (1) |
|
3.2 Disturbances of Growth or Metabolism |
|
|
305 | (2) |
|
|
307 | (1) |
|
3.4 Fracture and Callus Formation |
|
|
307 | (1) |
|
3.5 Increased Physeal Thickness and/or Physeal Dysplasia |
|
|
308 | (1) |
|
3.6 Decreased Physeal Thickness |
|
|
308 | (1) |
|
3.7 Degenerative Joint Disease |
|
|
309 | (1) |
|
3.8 Chondromucinous Degeneration |
|
|
310 | (1) |
|
|
310 | (1) |
|
3.10 Reactive New Bone Formation |
|
|
310 | (1) |
|
4 Hyperplastic and Neoplastic Lesions |
|
|
311 | (3) |
|
4.1 Hyperplastic Bone Lesions |
|
|
311 | (1) |
|
4.2 Hyperplastic Synovial Lesions |
|
|
311 | (1) |
|
|
311 | (2) |
|
|
313 | (1) |
|
|
314 | (9) |
Section VI Integumentary System |
|
|
|
|
|
|
323 | (1) |
|
2 Normal Skin and Subcutis |
|
|
324 | (3) |
|
|
324 | (1) |
|
2.2 Anatomy and Histology |
|
|
324 | (2) |
|
|
326 | (1) |
|
|
327 | (1) |
|
|
327 | (1) |
|
|
327 | (4) |
|
|
327 | (1) |
|
5.2 Epidermal Degeneration |
|
|
328 | (1) |
|
|
329 | (1) |
|
5.4 Erosion and Ulceration |
|
|
329 | (1) |
|
5.5 Tissue Necrosis and Apoptosis |
|
|
329 | (1) |
|
|
330 | (1) |
|
6 Hyperplastic and Neoplastic Lesions |
|
|
331 | (10) |
|
|
331 | (1) |
|
|
332 | (4) |
|
6.3 Mesodermal Non-Neoplastic Proliferative and Neoplasmic Lesions |
|
|
336 | (4) |
|
|
340 | (1) |
|
|
341 | (1) |
|
|
341 | (2) |
|
7.1 Non-Neoplastic Lesions |
|
|
341 | (1) |
|
|
342 | (1) |
|
|
343 | (4) |
|
20 Specialized Sebaceous Glands-Zymbal's Gland, Preputial Gland, Clitoral Gland, and Perianal Gland |
|
|
|
|
|
347 | (1) |
|
2 Normal Specialized Sebaceous Gland |
|
|
347 | (4) |
|
|
347 | (1) |
|
2.2 Anatomy and Histology |
|
|
348 | (2) |
|
|
350 | (1) |
|
|
351 | (1) |
|
|
351 | (1) |
|
|
352 | (1) |
|
6 Growth Disturbances (Non-Neoplastic) |
|
|
352 | (2) |
|
7 Growth Disturbances (Neoplastic) |
|
|
354 | (5) |
|
|
354 | (2) |
|
7.2 Preputial and Clitoral Glands |
|
|
356 | (3) |
|
7.3 Perianal (Circumanal) Glands |
|
|
359 | (1) |
|
|
359 | (4) |
|
|
363 | (1) |
|
|
363 | (6) |
Section VII Mammary Gland |
|
|
|
|
|
|
|
|
369 | (1) |
|
|
369 | (3) |
|
2.1 Embryology and Development |
|
|
369 | (2) |
|
|
371 | (1) |
|
|
371 | (1) |
|
|
372 | (1) |
|
|
372 | (2) |
|
5 Inflammatory and Vascular Lesions |
|
|
374 | (1) |
|
6 Hyperplastic and Neoplastic Lesions |
|
|
374 | (8) |
|
6.1 Lobular or Lobuloalveolar Hyperplasia |
|
|
375 | (1) |
|
6.2 Focal Hyperplasia with Cellular Atypia (Atypical Hyperplasia) |
|
|
375 | (1) |
|
|
376 | (3) |
|
|
379 | (1) |
|
|
380 | (1) |
|
|
380 | (2) |
|
|
382 | (1) |
|
|
382 | (1) |
|
|
383 | (4) |
|
|
387 | (4) |
Section VIII Respiratory Tract |
|
|
22 Nose, Larynx, and Trachea |
|
|
|
|
Kyathanahalli S. Janardhan |
|
|
|
|
|
|
391 | (1) |
|
2 Normal Upper Respiratory Tract |
|
|
392 | (10) |
|
|
392 | (1) |
|
2.2 Anatomy and Histology |
|
|
392 | (9) |
|
|
401 | (1) |
|
|
402 | (1) |
|
4 Degenerative, Regenerative, and Adaptive Lesions |
|
|
402 | (9) |
|
|
402 | (8) |
|
|
410 | (1) |
|
5 Inflammatory and Vascular Lesions |
|
|
411 | (4) |
|
6 Hyperplastic and Neoplastic Lesions |
|
|
415 | (11) |
|
|
416 | (6) |
|
|
422 | (4) |
|
|
426 | (2) |
|
|
426 | (2) |
|
|
428 | (3) |
|
8.1 Nasal Passages and Associated Structures |
|
|
429 | (1) |
|
|
430 | (1) |
|
|
431 | (1) |
|
9 Molecular Pathology of the Upper Respiratory Tract |
|
|
431 | (2) |
|
9.1 Alterations in Gene Expression |
|
|
431 | (1) |
|
9.2 Alterations in Protein Expression |
|
|
432 | (1) |
|
9.3 DNA Adducts and Mutations in Nasal Tumors |
|
|
432 | (1) |
|
|
433 | (2) |
|
Further Reading-Molecular pathology |
|
|
435 | (2) |
|
23 Lung, Pleura, and Mediastinum |
|
|
|
|
Kyathanahalli S. Janardhan |
|
|
|
|
|
|
|
437 | (1) |
|
|
438 | (5) |
|
|
438 | (1) |
|
|
439 | (1) |
|
|
440 | (3) |
|
|
443 | (1) |
|
|
443 | (1) |
|
|
444 | (2) |
|
|
444 | (1) |
|
4.2 Cilia-Associated Respiratory Bacillus (CAR Bacillus) |
|
|
444 | (1) |
|
4.3 Corynebacterium kutscheri |
|
|
444 | (1) |
|
|
445 | (1) |
|
|
445 | (1) |
|
|
445 | (1) |
|
|
446 | (1) |
|
5 Nonproliferative, Degenerative, and Vascular Lesions |
|
|
446 | (2) |
|
5.1 Degeneration and Necrosis |
|
|
446 | (1) |
|
|
446 | (1) |
|
5.3 Alveolar Proteinosis (Lipoproteinosis) |
|
|
446 | (1) |
|
5.4 Alveolar Histiocytosis (Infiltrate Cellular, Histiocyte) |
|
|
447 | (1) |
|
|
448 | (1) |
|
|
448 | (1) |
|
|
448 | (1) |
|
6 Nonneoplastic and Neoplastic Proliferative Lesions |
|
|
448 | (11) |
|
6.1 Regenerative Hyperplasia |
|
|
449 | (1) |
|
6.2 Primary Hyperplasia of the Alveolar Epithelium |
|
|
450 | (1) |
|
6.3 Bronchial Hyperplasia |
|
|
451 | (1) |
|
6.4 Mesothelial Hyperplasia |
|
|
451 | (1) |
|
6.5 Alveolar/Bronchiolar Adenoma and Carcinoma |
|
|
452 | (3) |
|
6.6 Bronchial Adenoma and Carcinoma |
|
|
455 | (1) |
|
6.7 Squamous Cell Carcinoma |
|
|
455 | (1) |
|
6.8 Cystic Keratinizing Epithelioma |
|
|
456 | (1) |
|
|
457 | (1) |
|
6.10 Malignant Mesothelioma |
|
|
457 | (1) |
|
6.11 Mediastinal Neoplasms |
|
|
458 | (1) |
|
6.12 Metastatic Neoplasms |
|
|
458 | (1) |
|
|
459 | (1) |
|
7.1 Gavage-Related Lesions |
|
|
459 | (1) |
|
|
459 | (1) |
|
7.3 Cartilaginous Metaplasia |
|
|
460 | (1) |
|
|
460 | (1) |
|
7.5 Goblet Cell Metaplasia |
|
|
460 | (1) |
|
|
460 | (3) |
|
8.1 Toxicity of Particles |
|
|
460 | (1) |
|
|
461 | (1) |
|
8.3 Toxicity of Chemicals Administered Systemically |
|
|
462 | (1) |
|
|
462 | (1) |
|
|
463 | (7) |
Section IX Immune System |
|
|
24 Spleen, Lymph Nodes, and Thymus |
|
|
|
|
|
470 | (1) |
|
|
470 | (1) |
|
|
470 | (1) |
|
|
470 | (1) |
|
|
470 | (1) |
|
|
471 | (1) |
|
|
472 | (1) |
|
|
472 | (1) |
|
|
472 | (1) |
|
|
472 | (1) |
|
|
473 | (1) |
|
7 Inflammatory and Vascular Lesions |
|
|
473 | (1) |
|
8 Hyperplastic and Neoplastic Lesions |
|
|
474 | (3) |
|
|
474 | (1) |
|
|
475 | (1) |
|
9.1 Large Granular Lymphocyte Leukemia |
|
|
475 | (2) |
|
10 Lymphoma and Other Hematopoietic Neoplasms |
|
|
477 | (1) |
|
|
477 | (2) |
|
11.1 Fibroma and Fibrosarcoma |
|
|
478 | (1) |
|
11.2 Leiomyoma and Leiomyosarcoma |
|
|
478 | (1) |
|
11.3 Hemangioma and Hemangiosarcoma |
|
|
478 | (1) |
|
|
478 | (1) |
|
11.5 Undifferentiated Sarcoma |
|
|
479 | (1) |
|
11.6 Malignant Schwannoma |
|
|
479 | (1) |
|
|
479 | (1) |
|
|
480 | (1) |
|
|
480 | (1) |
|
|
480 | (1) |
|
|
480 | (1) |
|
|
481 | (1) |
|
|
481 | (1) |
|
16.2 Anatomy and Histology |
|
|
481 | (1) |
|
|
482 | (1) |
|
|
482 | (1) |
|
19 Inflammatory and Vascular Lesions |
|
|
483 | (1) |
|
20 Hyperplastic and Neoplastic Lesions |
|
|
484 | (1) |
|
|
484 | (1) |
|
|
484 | (1) |
|
|
485 | (1) |
|
|
485 | (1) |
|
|
485 | (1) |
|
|
485 | (1) |
|
|
485 | (1) |
|
23.2 Anatomy and Histology |
|
|
485 | (1) |
|
|
486 | (1) |
|
|
486 | (1) |
|
|
486 | (2) |
|
26 Inflammatory and Vascular Lesions |
|
|
488 | (1) |
|
27 Hyperplastic and Neoplastic Lesions |
|
|
488 | (1) |
|
|
488 | (1) |
|
|
488 | (1) |
|
|
488 | (1) |
|
|
489 | (1) |
|
|
489 | (2) |
|
|
491 | (4) |
Section X Bone Marrow |
|
|
|
|
|
|
|
|
495 | (1) |
|
|
496 | (6) |
|
|
496 | (1) |
|
2.2 Structure and Function |
|
|
497 | (3) |
|
2.3 Hematopoiesis and the Hematopoietic Cells |
|
|
500 | (1) |
|
2.4 The Myeloid: Erythroid Ratio |
|
|
501 | (1) |
|
3 Disturbances in Hematopoietic Cell Growth |
|
|
502 | (7) |
|
3.1 Increased Cell Numbers |
|
|
503 | (3) |
|
3.2 Decreased Cell Numbers |
|
|
506 | (3) |
|
|
509 | (1) |
|
4 Alterations of Bone Marrow Stromal Cells |
|
|
509 | (3) |
|
|
509 | (1) |
|
4.2 Reactive Increases in Macrophages |
|
|
510 | (1) |
|
|
511 | (1) |
|
|
512 | (1) |
|
|
512 | (3) |
|
|
512 | (1) |
|
|
512 | (2) |
|
5.3 Gelatinous Transformation of Bone Marrow |
|
|
514 | (1) |
|
|
514 | (1) |
|
|
515 | (1) |
|
|
515 | (2) |
|
|
515 | (1) |
|
|
516 | (1) |
|
|
517 | (6) |
Section XI Female Reproductive Tract |
|
|
|
|
|
|
|
523 | (1) |
|
|
523 | (1) |
|
|
523 | (1) |
|
2.2 Anatomy and Histology |
|
|
524 | (1) |
|
|
524 | (1) |
|
|
524 | (1) |
|
4 Nonproliferative Lesions |
|
|
524 | (4) |
|
|
524 | (1) |
|
4.2 Decreased Number/Absence of Corpora Lutea |
|
|
525 | (1) |
|
4.3 Increased Size/Number of Corpora Lutea |
|
|
525 | (1) |
|
4.4 Degeneration Within Corpora Lutea |
|
|
526 | (1) |
|
|
526 | (1) |
|
|
526 | (1) |
|
4.7 Other Degenerative Lesions |
|
|
527 | (1) |
|
5 Hyperplastic and Neoplastic Lesions |
|
|
528 | (3) |
|
|
528 | (1) |
|
|
529 | (1) |
|
5.3 Benign and Malignant Granulosa Cell Tumors |
|
|
529 | (2) |
|
|
531 | (3) |
|
|
534 | (3) |
|
27 Oviduct, Uterus, and Vagina |
|
|
|
|
|
|
|
|
537 | (1) |
|
2 Normal Tubular Genital Organs |
|
|
537 | (3) |
|
|
537 | (1) |
|
|
538 | (1) |
|
|
539 | (1) |
|
|
540 | (1) |
|
|
540 | (1) |
|
|
541 | (1) |
|
5 Inflammatory and Vascular Lesions |
|
|
541 | (1) |
|
6 Nonproliferative Lesions |
|
|
541 | (2) |
|
|
541 | (1) |
|
|
542 | (1) |
|
|
542 | (1) |
|
|
542 | (1) |
|
|
543 | (1) |
|
|
543 | (1) |
|
7 Hyperplastic and Neoplastic Lesions |
|
|
543 | (9) |
|
|
543 | (1) |
|
|
544 | (7) |
|
|
551 | (1) |
|
|
552 | (2) |
|
|
554 | (3) |
|
|
557 | (6) |
Section XII Male Reproductive System |
|
|
|
|
|
|
|
563 | (1) |
|
2 Normal Testis and Epididymis |
|
|
563 | (5) |
|
|
563 | (1) |
|
2.2 Postnatal Development |
|
|
564 | (1) |
|
2.3 Anatomy and Histology |
|
|
564 | (3) |
|
|
567 | (1) |
|
|
568 | (1) |
|
|
568 | (1) |
|
5 Inflammatory and Vascular Lesions |
|
|
569 | (1) |
|
6 Hyperplastic and Neoplastic Lesions |
|
|
570 | (2) |
|
6.1 Hyperplasia and Adenoma of Interstitial Cells |
|
|
570 | (1) |
|
|
571 | (1) |
|
6.3 Rete Testis Neoplasms |
|
|
571 | (1) |
|
|
571 | (1) |
|
|
572 | (1) |
|
|
572 | (4) |
|
|
576 | (3) |
|
29 Male Accessory Sex Glands |
|
|
|
|
|
579 | (1) |
|
2 Normal Male Sex Glands and Organs |
|
|
579 | (5) |
|
|
579 | (1) |
|
|
580 | (4) |
|
|
584 | (1) |
|
|
584 | (1) |
|
5 Inflammatory and Vascular Lesions |
|
|
584 | (1) |
|
6 Hyperplastic and Neoplastic Lesions |
|
|
584 | (1) |
|
|
585 | (2) |
|
|
587 | (4) |
Section XIII Circulatory System |
|
|
|
|
|
|
|
|
|
|
|
591 | (2) |
|
|
592 | (1) |
|
|
593 | (1) |
|
2.1 Interventricular Septal Defect |
|
|
594 | (1) |
|
2.2 Hamartomas of Blood Vessels |
|
|
594 | (1) |
|
2.3 Patent Ductus Arteriosus |
|
|
594 | (1) |
|
2.4 Right-Sided Aortic Arch |
|
|
594 | (1) |
|
|
594 | (3) |
|
3.1 Vascular Ectasia/Angiectasis |
|
|
594 | (1) |
|
|
594 | (1) |
|
3.3 Focal Loss of Internal Elastic Lamina |
|
|
594 | (1) |
|
3.4 Intimal Proliferation |
|
|
594 | (1) |
|
|
595 | (1) |
|
|
595 | (1) |
|
3.7 Myocardial Degeneration |
|
|
595 | (1) |
|
3.8 Spontaneous Cardiomyopathy |
|
|
595 | (1) |
|
3.9 Mineralization (Calcification) |
|
|
595 | (2) |
|
3.10 Thrombosis and Aneurysms |
|
|
597 | (1) |
|
|
597 | (2) |
|
|
599 | (1) |
|
5.1 Endocardial Hyperplasia |
|
|
599 | (1) |
|
5.2 Myocardial Hyperplasia |
|
|
599 | (1) |
|
5.3 Proliferation and Hyperplasia of Blood Vessels |
|
|
600 | (1) |
|
|
600 | (3) |
|
|
600 | (1) |
|
|
601 | (2) |
|
|
603 | (1) |
|
|
603 | (1) |
|
|
603 | (9) |
|
|
603 | (1) |
|
7.2 Myocardial Degeneration and Necrosis |
|
|
603 | (4) |
|
7.3 Biomarkers of Cardiotoxicity |
|
|
607 | (1) |
|
7.4 Cardiac Weight Changes, Hypertrophy, and Atrophy |
|
|
608 | (2) |
|
7.5 Submicroscopic ("Occult") Cardiotoxicity |
|
|
610 | (1) |
|
7.6 Chemically Induced Cardiac Thrombosis |
|
|
611 | (1) |
|
|
611 | (1) |
|
|
612 | (1) |
|
8 Induced Lesions In Blood Vessels |
|
|
612 | (6) |
|
|
613 | (2) |
|
8.2 Immune-Mediated Vasculitis |
|
|
615 | (1) |
|
8.3 Hypertrophy, Hyperplasia, and Fibrosis |
|
|
616 | (1) |
|
8.4 Plexiform Vasculopathy |
|
|
616 | (1) |
|
|
616 | (1) |
|
8.6 Induced Degenerative Changes |
|
|
617 | (1) |
|
|
617 | (1) |
|
|
617 | (1) |
|
|
618 | (13) |
Section XIV Endocrine System |
|
|
|
|
|
|
|
631 | (1) |
|
|
631 | (4) |
|
|
631 | (2) |
|
|
633 | (1) |
|
|
634 | (1) |
|
|
635 | (1) |
|
|
635 | (1) |
|
|
636 | (2) |
|
5 Inflammatory and Vascular Lesions |
|
|
638 | (1) |
|
6 Hyperplastic and Neoplastic Lesions |
|
|
638 | (6) |
|
|
638 | (5) |
|
|
643 | (1) |
|
|
643 | (1) |
|
6.4 Miscellaneous Neoplasms |
|
|
644 | (1) |
|
|
644 | (1) |
|
|
645 | (1) |
|
|
645 | (4) |
|
|
|
|
|
|
649 | (1) |
|
|
649 | (3) |
|
|
649 | (1) |
|
|
650 | (1) |
|
|
650 | (1) |
|
|
651 | (1) |
|
|
652 | (1) |
|
3.1 Accessory (Adreno) Cortical Tissue |
|
|
652 | (1) |
|
|
653 | (1) |
|
|
653 | (2) |
|
|
653 | (1) |
|
4.2 Cortical Vacuolation (Fatty Change) |
|
|
653 | (1) |
|
|
654 | (1) |
|
|
654 | (1) |
|
|
654 | (1) |
|
|
654 | (1) |
|
4.7 Diffuse Lipid Depletion |
|
|
655 | (1) |
|
4.8 Extracapsular Cortical Tissue |
|
|
655 | (1) |
|
5 Inflammatory and Vascular Lesions |
|
|
655 | (1) |
|
6 Hyperplastic and Neoplastic Lesions |
|
|
655 | (9) |
|
|
655 | (4) |
|
|
659 | (5) |
|
|
664 | (1) |
|
|
664 | (1) |
|
|
664 | (1) |
|
|
664 | (2) |
|
|
664 | (2) |
|
|
666 | (1) |
|
|
666 | (3) |
|
|
|
|
|
|
669 | (1) |
|
|
669 | (3) |
|
|
669 | (1) |
|
|
670 | (1) |
|
|
670 | (1) |
|
|
671 | (1) |
|
|
672 | (1) |
|
|
673 | (1) |
|
5 Inflammatory and Vascular Lesions |
|
|
673 | (1) |
|
6 Hyperplastic and Neoplastic Lesions |
|
|
674 | (9) |
|
6.1 Follicular Epithelium |
|
|
674 | (5) |
|
6.2 C Cells (Parafollicular Cells) |
|
|
679 | (4) |
|
|
683 | (1) |
|
|
683 | (1) |
|
|
684 | (3) |
|
|
|
|
|
|
687 | (1) |
|
2 Normal Parathyroid Gland |
|
|
687 | (1) |
|
|
687 | (1) |
|
|
687 | (1) |
|
|
688 | (1) |
|
|
688 | (1) |
|
|
688 | (1) |
|
5 Inflammatory and Vascular Lesions |
|
|
689 | (1) |
|
6 Hyperplasia and Neoplastic Lesions |
|
|
689 | (3) |
|
|
689 | (1) |
|
|
690 | (1) |
|
|
691 | (1) |
|
|
692 | (1) |
|
|
692 | (1) |
|
|
692 | (3) |
|
|
|
|
|
|
695 | (1) |
|
2 Normal Endocrine Pancreas |
|
|
695 | (2) |
|
|
695 | (1) |
|
2.2 Anatomy and Histology |
|
|
695 | (2) |
|
|
697 | (1) |
|
|
697 | (1) |
|
|
697 | (1) |
|
5 Inflammatory and Vascular Lesions |
|
|
698 | (1) |
|
6 Hyperplastic and Neoplastic Lesions |
|
|
698 | (3) |
|
6.1 Islet Cell Hyperplasia |
|
|
698 | (1) |
|
6.2 Islet Cell Regeneration |
|
|
699 | (1) |
|
|
699 | (1) |
|
|
700 | (1) |
|
6.5 Mixed Acinar-Islet Cell Adenoma |
|
|
701 | (1) |
|
|
701 | (1) |
|
|
702 | (1) |
|
|
703 | (2) |
Index |
|
705 | |